Oridonin: targeting programmed cell death pathways as an anti-tumour agent

Area of Science:

• Pharmacology
• Molecular Biology
• Oncology

Background:

• Oridonin, a diterpenoid from traditional Chinese herbal medicine, exhibits significant anti-cancer properties.
• It is known to induce apoptosis (programmed cell death) and autophagy (cellular self-degradation) in cancer cells.
• The interplay between oridonin-induced apoptosis and autophagy and their underlying molecular mechanisms require further elucidation.

Purpose of the Study:

• To review updated research on oridonin-induced cell death signaling pathways.
• To highlight the roles of apoptosis and autophagy in various cancer types treated with oridonin.
• To discuss the cross-talk between oridonin-mediated apoptosis and autophagy in cancer.

Main Methods:

• Literature review of scientific studies on oridonin.
• Analysis of molecular mechanisms of oridonin-induced apoptosis and autophagy.
• Examination of signaling pathways involved in cancer cell death.

Main Results:

• Oridonin triggers distinct and interconnected signaling pathways leading to apoptosis and autophagy.
• The balance between apoptosis and autophagy induced by oridonin influences its anti-cancer effects.
• Evidence suggests oridonin's potential in targeting both cell death processes for therapeutic benefit.

Conclusions:

• Oridonin demonstrates significant potential as an anti-cancer agent by modulating apoptosis and autophagy.
• Understanding the cross-talk between these pathways is crucial for optimizing oridonin-based cancer therapeutics.
• Further investigation into oridonin's molecular targets may pave the way for novel anti-cancer drug development.